z-logo
Premium
Breast masses: Color Doppler, power Doppler, and spectral analysis findings
Author(s) -
Hayashi Nobuharu,
Miyamoto Yukio,
Nakata Norio,
Irie Takeo,
Ikegami Masahiro,
Asao Keiko,
Tada Shimpei
Publication year - 1998
Publication title -
journal of clinical ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.272
H-Index - 61
eISSN - 1097-0096
pISSN - 0091-2751
DOI - 10.1002/(sici)1097-0096(199806)26:5<231::aid-jcu1>3.0.co;2-d
Subject(s) - medicine , vascularity , power doppler , radiology , malignancy , color doppler , doppler effect , pathology , ultrasound , ultrasonography , physics , astronomy
Purpose To determine the diagnostic efficacy of power Doppler sonography (PDS) with spectral analysis for breast diseases, we retrospectively compared PDS and color Doppler sonography (CDS) in patients with breast lesions. Methods One hundred thirty‐eight women with palpable breast lesions were examined with PDS (65 women) and/or CDS (73 women). We calculated peak velocity, end‐diastolic velocity, pulsatility index (PI), and resistance index (RI). Results On a 4‐point subjective visual vascularity scale, PDS demonstrated higher vascularity than did CDS. Although smaller and more subtle vessels could be detected only with PDS, the PI and RI differed significantly between malignant and benign lesions when either PDS or CDS was used. However, logistic regression analysis showed that high PI and RI were associated with malignancy only when CDS was used. When PDS was used, PI was significantly higher in invasive ductal carcinomas with fibrous stroma and ill‐defined margins (associated with a poor prognosis) than in invasive ductal carcinomas without fibrous stroma or with well‐defined margins. Conclusions Doppler spectral analysis of malignant breast lesions using PDS may contribute to the determination of prognosis. © 1998 John Wiley & Sons, Inc. J Clin Ultrasound 26:231–238, 1998.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here